Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Samuel A. Collins
Samuel A. Collins is the director of the H.J. Ross Network, a consulting group for doctors on billing and collection for insurance claims. He is a featured speaker on billing and coding for the AAOM and the California State Oriental Medical Association, as well as many acupuncture colleges. You are encouraged to submit your billing questions to him at sam@hjrossnetwork.com.
Click here to visit columnist's Talk Back Forum.